| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Essay |
1 Departments of Family Medicine, Epidemiology, and Community Health, Virginia Commonwealth University, Fairfax, Va
2 Departments of Biostatistics and Family Medicine, Virginia Commonwealth University, Richmond, Va
CORRESPONDING AUTHOR: Steven H. Woolf, MD, MPH West Hospital 1200 East Broad Street PO Box 980251 MCV Station Richmond, VA 23298-0251
ABSTRACT
Society invests billions of dollars in the development of new drugs and technologies but comparatively little in the fidelity of health care, that is, improving systems to ensure the delivery of care to all patients in need. Using mathematical arguments and a nomogram, we demonstrate that technological advances must yield dramatic, often unrealistic increases in efficacy to do more good than could be accomplished by improving fidelity. In 2 examples (the development of anti-platelet agents and statins), we show that enhanced efficacy failed to achieve the health gains that would have occurred by delivering older agents to all eligible patients. Society’s huge investment in technological innovations that only modestly improve efficacy, by consuming resources needed for improved delivery of care, may cost more lives than it saves. The misalignment of priorities is driven partly by the commercial interests of industry and by the public’s appetite for technological breakthroughs, but health outcomes ultimately suffer. Health, economic, and moral arguments make the case for spending less on technological advances and more on improving systems for delivering care.
Key Words: Allocation of resources • delivery of health care • priority setting • disparities • quality of health care
This article has been cited by other articles:
|
|
 |
|
  C. Clancy Improving Care Quality and Reducing Disparities: Physicians' Roles Arch Intern Med, June 9, 2008; 168(11): 1135 - 1136. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Leroy and P. Menon From Efficacy to Public Health Impact: A Call for Research on Program Delivery and Utilization in Nutrition J. Nutr., March 1, 2008; 138(3): 628 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Woolf The Meaning of Translational Research and Why It Matters JAMA, January 9, 2008; 299(2): 211 - 213. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Beasley, B. Starfield, C. van Weel, W. W. Rosser, and C. L. Haq Global Health and Primary Care Research J Am Board Fam Med, November 1, 2007; 20(6): 518 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. van Driel, M. Maier, and J. D. Maeseneer Measuring the impact of family medicine research: scientific citations or societal impact? Fam. Pract., October 1, 2007; 24(5): 401 - 402. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Leroy, J.-P. Habicht, G. Pelto, and S. M. Bertozzi LEROY ET AL. RESPOND Am J Public Health, October 1, 2007; 97(10): 1733 - 1733. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Woolf and R. E. Johnson INATTENTION TO THE FIDELITY OF HEALTH CARE DELIVERY IS COSTING LIVES Am J Public Health, October 1, 2007; 97(10): 1732 - 1733. [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Stange and W. R. Phillips In This Issue: Real Change Is Real Hard in the Real World Ann. Fam. Med, March 1, 2007; 5(2): 98 - 100. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Woolf Potential Health and Economic Consequences of Misplaced Priorities JAMA, February 7, 2007; 297(5): 523 - 526. [Full Text] [PDF]
|
|
|
|
|
|
K. C. Stange In This Issue: Trade-Offs, Time Use, Depression Care Ann. Fam. Med, November 1, 2005; 3(6): 482 - 483. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Teutsch and M. L. Berger Misaligned Incentives in America's Health: Who's Minding the Store? Ann. Fam. Med, November 1, 2005; 3(6): 485 - 487. [Full Text] [PDF]
|
|
Read all TRACK Comments
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
